Skip to main content
SpringerLink
Log in
Book cover

Current and Emerging Therapies in Pancreatic Cancer pp 151–169Cite as

Advanced Endoscopic Procedures

  • Chapter
  • First Online:

  • 982 Accesses

Abstract

Advanced endoscopic procedures defined as endoscopic ultrasound (EUS), endoscopic retrograde cholangiopancreatography (ERCP), and endoscopic enteral stent placement have a very central and important role in the diagnosis, treatment, and palliation of patients with pancreatic cancer. They are used as part of a multidisciplinary management approach which also includes both radiologic and surgical approaches to management of patients with pancreatic cancer. This chapter will review the role of these advanced endoscopic procedures in pancreatic cancer.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. DeWitt J, et al. Comparison of endoscopic ultrasonography and multidetector computed tomography for detecting and staging pancreatic cancer. Ann Intern Med. 2004;141(10):753–63.

    Article  PubMed  Google Scholar 

  2. Brand B, et al. Endoscopic ultrasound for differential diagnosis of focal pancreatic lesions, confirmed by surgery. Scand J Gastroenterol. 2000;35(11):1221–8.

    Article  CAS  PubMed  Google Scholar 

  3. Hewitt MJ, et al. EUS-guided FNA for diagnosis of solid pancreatic neoplasms: a meta-analysis. Gastrointest Endosc. 2012;75(2):319–31.

    Article  PubMed  Google Scholar 

  4. Chari ST, et al. Early detection of sporadic pancreatic cancer: summative review. Pancreas. 2015;44(5):693–712.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Canto MI, et al. International cancer of the pancreas screening (CAPS) consortium summit on the management of patients with increased risk for familial pancreatic cancer. Gut. 2013;62(3):339–47.

    Article  PubMed  Google Scholar 

  6. Canto MI, et al. Frequent detection of pancreatic lesions in asymptomatic high-risk individuals. Gastroenterology. 2012;142(4):796–804. quiz e14-5

    Article  PubMed  PubMed Central  Google Scholar 

  7. Brune K, et al. Multifocal neoplastic precursor lesions associated with lobular atrophy of the pancreas in patients having a strong family history of pancreatic cancer. Am J Surg Pathol. 2006;30(9):1067–76.

    PubMed  PubMed Central  Google Scholar 

  8. Brentnall TA, et al. Early diagnosis and treatment of pancreatic dysplasia in patients with a family history of pancreatic cancer. Ann Intern Med. 1999;131(4):247–55.

    Article  CAS  PubMed  Google Scholar 

  9. Kanda M, et al. Mutant GNAS detected in duodenal collections of secretin-stimulated pancreatic juice indicates the presence or emergence of pancreatic cysts. Gut. 2013;62(7):1024–33.

    Article  CAS  PubMed  Google Scholar 

  10. Eshleman JR, et al. KRAS and guanine nucleotide-binding protein mutations in pancreatic juice collected from the duodenum of patients at high risk for neoplasia undergoing endoscopic ultrasound. Clin Gastroenterol Hepatol. 2015;13(5):963–9. e4

    Article  CAS  PubMed  Google Scholar 

  11. Farrell JJ, Fernandez-del Castillo C. Pancreatic cystic neoplasms: management and unanswered questions. Gastroenterology. 2013;144(6):1303–15.

    Article  PubMed  Google Scholar 

  12. Farrell JJ. Prevalence, diagnosis and Management of Pancreatic Cystic Neoplasms: current status and future directions. Gut Liver. 2015;9(5):571–89.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Tanaka M, et al. International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology. 2012;12(3):183–97.

    Article  PubMed  Google Scholar 

  14. Vege SS, et al. American gastroenterological association institute guideline on the diagnosis and management of asymptomatic neoplastic pancreatic cysts. Gastroenterology. 2015;148(4):819–22. quize12-3

    Article  PubMed  Google Scholar 

  15. Perez-Johnston R, Sainani NI, Sahani DV. Imaging of chronic pancreatitis (including groove and autoimmune pancreatitis). Radiol Clin N Am. 2012;50(3):447–66.

    Article  PubMed  Google Scholar 

  16. Rosch T, et al. Endoscopic ultrasound in pancreatic tumor diagnosis. Gastrointest Endosc. 1991;37(3):347–52.

    Article  CAS  PubMed  Google Scholar 

  17. Madhani K, Farrell JJ. Autoimmune pancreatitis: an update on diagnosis and management. Gastroenterol Clin N Am. 2016;45(1):29–43.

    Article  Google Scholar 

  18. Takuma K, et al. Strategy to differentiate autoimmune pancreatitis from pancreas cancer. World J Gastroenterol. 2012;18(10):1015–20.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Kubota K, et al. A proposal for differentiation between early- and advanced-stage autoimmune pancreatitis by endoscopic ultrasonography. Dig Endosc. 2009;21(3):162–9.

    Article  PubMed  Google Scholar 

  20. Farrell JJ, et al. EUS findings in patients with autoimmune pancreatitis. Gastrointest Endosc. 2004;60(6):927–36.

    Article  PubMed  Google Scholar 

  21. Buscarini E, et al. Endoscopic ultrasonography findings in autoimmune pancreatitis. World J Gastroenterol. 2011;17(16):2080–5.

    Article  PubMed  PubMed Central  Google Scholar 

  22. El H II, et al. Endoscopic ultrasound-guided biopsy of pancreatic metastases: a large single-center experience. Pancreas. 2013;42(3):524–30.

    Article  Google Scholar 

  23. DeWitt J, et al. EUS-guided FNA of pancreatic metastases: a multicenter experience. Gastrointest Endosc. 2005;61(6):689–96.

    Article  PubMed  Google Scholar 

  24. Zhang Y, et al. Preoperative vascular evaluation with computed tomography and magnetic resonance imaging for pancreatic cancer: a meta-analysis. Pancreatology. 2012;12(3):227–33.

    Article  PubMed  Google Scholar 

  25. Brugge WR, et al. The use of EUS to diagnose malignant portal venous system invasion by pancreatic cancer. Gastrointest Endosc. 1996;43(6):561–7.

    Article  CAS  PubMed  Google Scholar 

  26. Rosch T, et al. Endoscopic ultrasound criteria for vascular invasion in the staging of cancer of the head of the pancreas: a blind reevaluation of videotapes. Gastrointest Endosc. 2000;52(4):469–77.

    Article  CAS  PubMed  Google Scholar 

  27. Dewitt J, et al. Comparison of endoscopic ultrasound and computed tomography for the preoperative evaluation of pancreatic cancer: a systematic review. Clin Gastroenterol Hepatol. 2006;4(6):717–25. quiz 664

    Article  PubMed  Google Scholar 

  28. tenBerge J, et al. EUS-guided fine needle aspiration of the liver: indications, yield, and safety based on an international survey of 167 cases. Gastrointest Endosc. 2002;55(7):859–62.

    Article  PubMed  Google Scholar 

  29. Wagner M, et al. CT evaluation after neoadjuvant FOLFIRINOX chemotherapy for borderline and locally advanced pancreatic adenocarcinoma. Eur Radiol. 2017;27(7):3104–16.

    Google Scholar 

  30. Xia, B.T., et al., Does radiologic response correlate to pathologic response in patients undergoing neoadjuvant therapy for borderline respectable pancreatic malignancy? J Surg Oncol, 2017; 115(4):376–383.

    Google Scholar 

  31. Donahue TR, et al. Downstaging chemotherapy and alteration in the classic computed tomography/magnetic resonance imaging signs of vascular involvement in patients with pancreaticobiliary malignant tumors: influence on patient selection for surgery. Arch Surg. 2011;146(7):836–43.

    Article  PubMed  Google Scholar 

  32. Lee JG, Leung J. Tissue sampling at ERCP in suspected pancreatic cancer. Gastrointest Endosc Clin N Am. 1998;8(1):221–35.

    CAS  PubMed  Google Scholar 

  33. Wiersema MJ, et al. Endosonography-guided fine-needle aspiration biopsy: diagnostic accuracy and complication assessment. Gastroenterology. 1997;112(4):1087–95.

    Article  CAS  PubMed  Google Scholar 

  34. Puli SR, et al. How good is endoscopic ultrasound-guided fine-needle aspiration in diagnosing the correct etiology for a solid pancreatic mass?: a meta-analysis and systematic review. Pancreas. 2013;42(1):20–6.

    Article  PubMed  Google Scholar 

  35. Savides TJ. Tricks for improving EUS-FNA accuracy and maximizing cellular yield. Gastrointest Endosc. 2009;69(2 Suppl):S130–3.

    Article  PubMed  Google Scholar 

  36. Varadarajulu S, Bang JY, Hebert-Magee S. Assessment of the technical performance of the flexible 19-gauge EUS-FNA needle. Gastrointest Endosc. 2012;76(2):336–43.

    Article  PubMed  Google Scholar 

  37. Harewood GC, Wiersema MJ. Endosonography-guided fine needle aspiration biopsy in the evaluation of pancreatic masses. Am J Gastroenterol. 2002;97(6):1386–91.

    Article  PubMed  Google Scholar 

  38. Horwhat JD, et al. A randomized comparison of EUS-guided FNA versus CT or US-guided FNA for the evaluation of pancreatic mass lesions. Gastrointest Endosc. 2006;63(7):966–75.

    Article  PubMed  Google Scholar 

  39. Volmar KE, et al. Pancreatic FNA in 1000 cases: a comparison of imaging modalities. Gastrointest Endosc. 2005;61(7):854–61.

    Article  PubMed  Google Scholar 

  40. Wang W, et al. Use of EUS-FNA in diagnosing pancreatic neoplasm without a definitive mass on CT. Gastrointest Endosc. 2013;78(1):73–80.

    Article  PubMed  Google Scholar 

  41. Micames C, et al. Lower frequency of peritoneal carcinomatosis in patients with pancreatic cancer diagnosed by EUS-guided FNA vs. percutaneous FNA. Gastrointest Endosc. 2003;58(5):690–5.

    Article  PubMed  Google Scholar 

  42. Eloubeidi MA, et al. Acute pancreatitis after EUS-guided FNA of solid pancreatic masses: a pooled analysis from EUS centers in the United States. Gastrointest Endosc. 2004;60(3):385–9.

    Article  PubMed  Google Scholar 

  43. Eloubeidi MA, et al. Frequency of major complications after EUS-guided FNA of solid pancreatic masses: a prospective evaluation. Gastrointest Endosc. 2006;63(4):622–9.

    Article  PubMed  Google Scholar 

  44. Tierney WM, et al. The clinical and economic impact of alternative staging strategies for adenocarcinoma of the pancreas. Am J Gastroenterol. 2000;95(7):1708–13.

    Article  CAS  PubMed  Google Scholar 

  45. Harewood GC, Wiersema MJ. A cost analysis of endoscopic ultrasound in the evaluation of pancreatic head adenocarcinoma. Am J Gastroenterol. 2001;96(9):2651–6.

    Article  CAS  PubMed  Google Scholar 

  46. Mertz H, Gautam S. The learning curve for EUS-guided FNA of pancreatic cancer. Gastrointest Endosc. 2004;59(1):33–7.

    Article  PubMed  Google Scholar 

  47. Klapman JB, et al. Clinical impact of on-site cytopathology interpretation on endoscopic ultrasound-guided fine needle aspiration. Am J Gastroenterol. 2003;98(6):1289–94.

    Article  PubMed  Google Scholar 

  48. Farrell JJ. Diagnosing pancreatic malignancy in the setting of chronic pancreatitis: is there room for improvement? Gastrointest Endosc. 2005;62(5):737–41.

    Article  PubMed  Google Scholar 

  49. Varadarajulu S, Tamhane A, Eloubeidi MA. Yield of EUS-guided FNA of pancreatic masses in the presence or the absence of chronic pancreatitis. Gastrointest Endosc. 2005;62(5):728–36; quiz 751, 753.

    Article  PubMed  Google Scholar 

  50. Fritscher-Ravens A, et al. Comparison of endoscopic ultrasound-guided fine needle aspiration for focal pancreatic lesions in patients with normal parenchyma and chronic pancreatitis. Am J Gastroenterol. 2002;97(11):2768–75.

    Article  PubMed  Google Scholar 

  51. Atiq M, et al. Role of endoscopic ultrasonography in evaluation of metastatic lesions to the pancreas: a tertiary cancer center experience. Pancreas. 2013;42(3):516–23.

    Article  PubMed  Google Scholar 

  52. Tharian B, et al. Endoscopic ultrasound fine needle aspiration: technique and applications in clinical practice. World J Gastrointest Endosc. 2012;4(12):532–44.

    Article  PubMed  PubMed Central  Google Scholar 

  53. Varadarajulu S, Fockens P, Hawes RH. Best practices in endoscopic ultrasound-guided fine-needle aspiration. Clin Gastroenterol Hepatol. 2012;10(7):697–703.

    Article  PubMed  Google Scholar 

  54. Weston BR, Bhutani MS. Optimizing diagnostic yield for EUS-guided sampling of solid pancreatic lesions: a technical review. Gastroenterol Hepatol (N Y). 2013;9(6):352–63.

    Google Scholar 

  55. Polkowski M, et al. Learning, techniques, and complications of endoscopic ultrasound (EUS)-guided sampling in gastroenterology: European Society of Gastrointestinal Endoscopy (ESGE) technical guideline. Endoscopy. 2012;44(2):190–206.

    Article  CAS  PubMed  Google Scholar 

  56. Varadarajulu S, et al. Endoscopic ultrasound-guided tissue acquisition. Dig Endosc. 2014;26(Suppl 1):62–9.

    Article  PubMed  Google Scholar 

  57. Panic N, Larghi A. Techniques for endoscopic ultrasound-guided fine-needle biopsy. Gastrointest Endosc Clin N Am. 2014;24(1):83–107.

    Article  PubMed  Google Scholar 

  58. Donahue TR, et al. Stromal MicroRNA-21 levels predict response to 5-fluorouracil in patients with pancreatic cancer. J Surg Oncol. 2014;110(8):952–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  59. Neuzillet C, et al. Stromal expression of SPARC in pancreatic adenocarcinoma. Cancer Metastasis Rev. 2013;32(3–4):585–602.

    Article  CAS  PubMed  Google Scholar 

  60. Simone NL, et al. Laser capture microdissection: beyond functional genomics to proteomics. Mol Diagn. 2000;5(4):301–7.

    Article  CAS  PubMed  Google Scholar 

  61. Larghi A, et al. Feasibility and yield of a novel 22-gauge histology EUS needle in patients with pancreatic masses: a multicenter prospective cohort study. Surg Endosc. 2013;27(10):3733–8.

    Article  PubMed  Google Scholar 

  62. Iwashita T, et al. High single-pass diagnostic yield of a new 25-gauge core biopsy needle for EUS-guided FNA biopsy in solid pancreatic lesions. Gastrointest Endosc. 2013;77(6):909–15.

    Article  PubMed  Google Scholar 

  63. Saftoiu A, et al. Neural network analysis of dynamic sequences of EUS elastography used for the differential diagnosis of chronic pancreatitis and pancreatic cancer. Gastrointest Endosc. 2008;68(6):1086–94.

    Article  PubMed  Google Scholar 

  64. Fuccio L, et al. The role of K-ras gene mutation analysis in EUS-guided FNA cytology specimens for the differential diagnosis of pancreatic solid masses: a meta-analysis of prospective studies. Gastrointest Endosc. 2013;78(4):596–608.

    Article  PubMed  Google Scholar 

  65. Luz LP, Al-Haddad MA, DeWitt JA. EUS-guided celiac plexus interventions in pancreatic cancer pain: an update and controversies for the endosonographer. Endosc Ultrasound. 2014;3(4):213–20.

    Article  PubMed  PubMed Central  Google Scholar 

  66. Fujii-Lau LL, et al. Impact of celiac neurolysis on survival in patients with pancreatic cancer. Gastrointest Endosc. 2015;82(1):46–56. e2

    Article  PubMed  Google Scholar 

  67. Kaufman M, et al. Efficacy of endoscopic ultrasound-guided celiac plexus block and celiac plexus neurolysis for managing abdominal pain associated with chronic pancreatitis and pancreatic cancer. J Clin Gastroenterol. 2010;44(2):127–34.

    Article  PubMed  Google Scholar 

  68. Doi S, et al. Endoscopic ultrasound-guided celiac ganglia neurolysis vs. celiac plexus neurolysis: a randomized multicenter trial. Endoscopy. 2013;45(5):362–9.

    Article  CAS  PubMed  Google Scholar 

  69. DiMaio CJ, et al. EUS-guided fiducial placement for image-guided radiation therapy in GI malignancies by using a 22-gauge needle (with videos). Gastrointest Endosc. 2010;71(7):1204–10.

    Article  PubMed  Google Scholar 

  70. Pishvaian AC, et al. EUS-guided fiducial placement for CyberKnife radiotherapy of mediastinal and abdominal malignancies. Gastrointest Endosc. 2006;64(3):412–7.

    Article  PubMed  Google Scholar 

  71. Park WG, et al. EUS-guided gold fiducial insertion for image-guided radiation therapy of pancreatic cancer: 50 successful cases without fluoroscopy. Gastrointest Endosc. 2010;71(3):513–8.

    Article  PubMed  Google Scholar 

  72. Varadarajulu S, et al. The use of endoscopic ultrasound-guided gold markers in image-guided radiation therapy of pancreatic cancers: a case series. Endoscopy. 2010;42(5):423–5.

    Article  CAS  PubMed  Google Scholar 

  73. Farrell JJ, Sherrod A, Parekh D. EUS-guided fine-needle tattooing for preoperative localization of early pancreatic adenocarcinoma. Gastrointest Endosc. 2009;69(1):176–7.

    Article  PubMed  Google Scholar 

  74. Lennon AM, et al. EUS-guided tattooing before laparoscopic distal pancreatic resection (with video). Gastrointest Endosc. 2010;72(5):1089–94.

    Article  PubMed  Google Scholar 

  75. Larsen MH, Fristrup CW, Mortensen MB. Endoscopic ultrasound-guided fine-needle marking of a small pancreatic tumor. Endoscopy. 2009;41(Suppl 2):E175–6.

    Article  PubMed  Google Scholar 

  76. Hecht JR, et al. EUS or percutaneously guided intratumoral TNFerade biologic with 5-fluorouracil and radiotherapy for first-line treatment of locally advanced pancreatic cancer: a phase I/II study. Gastrointest Endosc. 2012;75(2):332–8.

    Article  PubMed  PubMed Central  Google Scholar 

  77. Jurgensen C, et al. EUS-guided alcohol ablation of an insulinoma. Gastrointest Endosc. 2006;63(7):1059–62.

    Article  PubMed  Google Scholar 

  78. Levy MJ, et al. US-guided ethanol ablation of insulinomas: a new treatment option. Gastrointest Endosc. 2012;75(1):200–6.

    Article  PubMed  Google Scholar 

  79. Du YQ, Li ZS, Jin ZD. Endoscope-assisted brachytherapy for pancreatic cancer: from tumor killing to pain relief and drainage. J Interv Gastroenterol. 2011;1(1):23–7.

    Article  PubMed  PubMed Central  Google Scholar 

  80. Jin Z, et al. Endoscopic ultrasonography-guided interstitial implantation of iodine 125-seeds combined with chemotherapy in the treatment of unresectable pancreatic carcinoma: a prospective pilot study. Endoscopy. 2008;40(4):314–20.

    Article  CAS  PubMed  Google Scholar 

  81. Poincloux L, et al. Endoscopic ultrasound-guided biliary drainage after failed ERCP: cumulative experience of 101 procedures at a single center. Endoscopy. 2015;47(9):794–801.

    Article  PubMed  Google Scholar 

  82. Weilert F. Prospective evaluation of simplified algorithm for EUS-guided intra-hepatic biliary access and anterograde interventions for failed ERCP. Surg Endosc. 2014;28(11):3193–9.

    Article  PubMed  Google Scholar 

  83. Oterdoom LH, van Weyenberg SJ, de Boer NK. Double-duct sign: do not forget the gallstones. J Gastrointestin Liver Dis. 2013;22(4):447–50.

    PubMed  Google Scholar 

  84. Scheiman JM, et al. Can endoscopic ultrasound or magnetic resonance cholangiopancreatography replace ERCP in patients with suspected biliary disease? A prospective trial and cost analysis. Am J Gastroenterol. 2001;96(10):2900–4.

    Article  CAS  PubMed  Google Scholar 

  85. Jailwala J, et al. Triple-tissue sampling at ERCP in malignant biliary obstruction. Gastrointest Endosc. 2000;51(4 Pt 1):383–90.

    Article  CAS  PubMed  Google Scholar 

  86. Parsi MA, et al. Factors affecting the yield of brush cytology for the diagnosis of pancreatic and biliary cancers. Pancreas. 2011;40(1):52–4.

    Article  PubMed  Google Scholar 

  87. Parsi MA, et al. Diagnostic and therapeutic cholangiopancreatoscopy: performance of a new digital cholangioscope. Gastrointest Endosc. 2014;79(6):936–42.

    Article  PubMed  Google Scholar 

  88. Murakami M, et al. Bypass surgery or stent placement for biliary obstruction in patients with unresectable pancreatic cancer. Gan To Kagaku Ryoho. 2013;40(12):1705–7.

    PubMed  Google Scholar 

  89. Yamamoto R, et al. Comparison of endoscopic stenting for malignant biliary obstruction: a single-center study. World J Gastrointest Endosc. 2015;7(9):889–94.

    Article  PubMed  PubMed Central  Google Scholar 

  90. Kofokotsios A, et al. Palliation with endoscopic metal stents may be preferable to surgical intervention for patients with obstructive pancreatic head adenocarcinoma. Int Surg. 2015;100(6):1104–10.

    Article  PubMed  PubMed Central  Google Scholar 

  91. Moss AC, et al. Do the benefits of metal stents justify the costs? A systematic review and meta-analysis of trials comparing endoscopic stents for malignant biliary obstruction. Eur J Gastroenterol Hepatol. 2007;19(12):1119–24.

    Article  CAS  PubMed  Google Scholar 

  92. Moss AC, Morris E, Mac Mathuna P. Palliative biliary stents for obstructing pancreatic carcinoma. Cochrane Database Syst Rev. 2006;1:CD004200.

    Google Scholar 

  93. Almadi MA, Barkun AN, Martel M. No benefit of covered vs uncovered self-expandable metal stents in patients with malignant distal biliary obstruction: a meta-analysis. Clin Gastroenterol Hepatol. 2013;11(1):27–37. e1

    Article  PubMed  Google Scholar 

  94. Saleem A, et al. Meta-analysis of randomized trials comparing the patency of covered and uncovered self-expandable metal stents for palliation of distal malignant bile duct obstruction. Gastrointest Endosc. 2011;74(2):321–7. e1-3

    Article  PubMed  Google Scholar 

  95. Cote GA, Sherman S. Endoscopic palliation of pancreatic cancer. Cancer J. 2012;18(6):584–90.

    Article  PubMed  PubMed Central  Google Scholar 

  96. van der Gaag NA, et al. Preoperative biliary drainage for cancer of the head of the pancreas. N Engl J Med. 2010;362(2):129–37.

    Article  PubMed  Google Scholar 

  97. Fang Y, et al. Pre-operative biliary drainage for obstructive jaundice. Cochrane Database Syst Rev. 2012;9:CD005444.

    PubMed Central  Google Scholar 

  98. Abrams RA, et al. Combined modality treatment of resectable and borderline resectable pancreas cancer: expert consensus statement. Ann Surg Oncol. 2009;16(7):1751–6.

    Article  PubMed  Google Scholar 

  99. Mullen JT, et al. Pancreaticoduodenectomy after placement of endobiliary metal stents. J Gastrointest Surg. 2005;9(8):1094–104. discussion 1104-5

    Article  PubMed  Google Scholar 

  100. Wasan SM, et al. Use of expandable metallic biliary stents in resectable pancreatic cancer. Am J Gastroenterol. 2005;100(9):2056–61.

    Article  PubMed  Google Scholar 

  101. Adler DG, Baron TH. Endoscopic palliation of malignant gastric outlet obstruction using self-expanding metal stents: experience in 36 patients. Am J Gastroenterol. 2002;97(1):72–8.

    Article  PubMed  Google Scholar 

  102. Espinel J, et al. Palliative treatment of malignant obstruction of gastric outlet using an endoscopically placed enteral Wallstent. Dig Dis Sci. 2001;46(11):2322–4.

    Article  CAS  PubMed  Google Scholar 

  103. Lopera JE, et al. Gastroduodenal stent placement: current status. Radiographics. 2004;24(6):1561–73.

    Article  PubMed  Google Scholar 

  104. Del Piano M, et al. Endoscopy or surgery for malignant GI outlet obstruction? Gastrointest Endosc. 2005;61(3):421–6.

    Article  PubMed  Google Scholar 

  105. Wong YT, et al. Gastric outlet obstruction secondary to pancreatic cancer: surgical vs endoscopic palliation. Surg Endosc. 2002;16(2):310–2.

    Article  CAS  PubMed  Google Scholar 

  106. Bessoud B, et al. Malignant gastroduodenal obstruction: palliation with self-expanding metallic stents. J Vasc Interv Radiol. 2005;16(2 Pt 1):247–53.

    Article  PubMed  Google Scholar 

  107. Brune IB, et al. Laparoscopic gastrojejunostomy and endoscopic biliary stent placement for palliation of incurable gastric outlet obstruction with cholestasis. Surg Endosc. 1997;11(8):834–7.

    Article  CAS  PubMed  Google Scholar 

  108. Holt AP, Patel M, Ahmed MM. Palliation of patients with malignant gastroduodenal obstruction with self-expanding metallic stents: the treatment of choice? Gastrointest Endosc. 2004;60(6):1010–7.

    Article  PubMed  Google Scholar 

  109. Kim JH, et al. Self-expanding coil stent with a long delivery system for palliation of unresectable malignant gastric outlet obstruction: a prospective study. Endoscopy. 2001;33(10):838–42.

    Article  CAS  PubMed  Google Scholar 

  110. Telford JJ, et al. Palliation of patients with malignant gastric outlet obstruction with the enteral Wallstent: outcomes from a multicenter study. Gastrointest Endosc. 2004;60(6):916–20.

    Article  PubMed  Google Scholar 

  111. Song HY, et al. A dual expandable nitinol stent: experience in 102 patients with malignant gastroduodenal strictures. J Vasc Interv Radiol. 2004;15(12):1443–9.

    Article  PubMed  Google Scholar 

  112. Jeurnink SM, et al. Surgical gastrojejunostomy or endoscopic stent placement for the palliation of malignant gastric outlet obstruction (SUSTENT study): a multicenter randomized trial. Gastrointest Endosc. 2010;71(3):490–9.

    Article  PubMed  Google Scholar 

  113. Tringali A, et al. Endoscopic treatment of malignant gastric and duodenal strictures: a prospective, multicenter study. Gastrointest Endosc. 2014;79(1):66–75.

    Article  PubMed  Google Scholar 

  114. Hosono S, et al. Endoscopic stenting versus surgical gastroenterostomy for palliation of malignant gastroduodenal obstruction: a meta-analysis. J Gastroenterol. 2007;42(4):283–90.

    Article  PubMed  Google Scholar 

  115. Jeurnink, S.M., et al., Stent versus gastrojejunostomy for the palliation of gastric outlet obstruction: a systematic review. J Gastroenterol. 2010;45(5):537–43.

    Google Scholar 

  116. Fiori E, et al. Palliative management of malignant antro-pyloric strictures. Gastroenterostomy vs. endoscopic stenting. A randomized prospective trial. Anticancer Res. 2004;24(1):269–71.

    PubMed  Google Scholar 

  117. Mehta S, et al. Prospective randomized trial of laparoscopic gastrojejunostomy versus duodenal stenting for malignant gastric outflow obstruction. Surg Endosc. 2006;20(2):239–42.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Yale Pancreatic Disease Program, Interventional Endoscopy, Yale University School of Medicine, LMP 1080, 15 York Street, New Haven, CT, 06510-3221, USA

    James J. Farrell M.D.

Authors
  1. James J. Farrell M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to James J. Farrell M.D. .

Editor information

Editors and Affiliations

  1. Mayo Clinic Cancer Center, Scottsdale, Arizona, USA

    Tanios Bekaii-Saab

  2. Winship Cancer Institute, Emory University, Atlanta, Georgia, USA

    Bassel El-Rayes

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this chapter

Cite this chapter

Farrell, J.J. (2018). Advanced Endoscopic Procedures. In: Bekaii-Saab, T., El-Rayes, B. (eds) Current and Emerging Therapies in Pancreatic Cancer . Springer, Cham. https://doi.org/10.1007/978-3-319-58256-6_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-58256-6_8

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-58255-9

  • Online ISBN: 978-3-319-58256-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation